Covalon Technologies (OTCMKTS:CVALF) Shares Up 3.3% – Still a Buy?

Covalon Technologies Ltd. (OTCMKTS:CVALF)’s share price rose 3.3% during trading on Thursday . The stock traded as high as $2.67 and last traded at $2.65. Approximately 21,758 shares traded hands during trading, an increase of 6% from the average daily volume of 20,557 shares. The stock had previously closed at $2.5650.

Covalon Technologies Stock Performance

The stock has a fifty day simple moving average of $1.86 and a two-hundred day simple moving average of $1.58. The stock has a market cap of $73.19 million, a PE ratio of 24.09 and a beta of 0.64.

Covalon Technologies (OTCMKTS:CVALF) last posted its earnings results on Thursday, August 27th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of $0.01 by $0.06. The firm had revenue of $7.07 million during the quarter, compared to analysts’ expectations of $6.65 million. Covalon Technologies had a net margin of 12.77% and a return on equity of 15.54%.

About Covalon Technologies

Covalon Technologies Ltd. is a Canadian medical technology company focused on developing and commercializing advanced healthcare products. Its activities center on wound care, infection prevention and surgical applications, with technologies designed to help protect tissue, support healing and improve the management of medical procedures.

The company’s product portfolio includes collagen-based wound care products marketed under the ColActive brand, as well as antimicrobial and protective coatings, dressings and other medical devices.